TrialBritish journal of cancer1998

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.

T Saarto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.